Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
asthma medication
|
| gptkbp:activeDuring |
albuterol
|
| gptkbp:availableIn |
various countries
|
| gptkbp:availableSizes |
90 mcg per actuation
|
| gptkbp:brand |
gptkb:Ventolin
|
| gptkbp:clinicalTrials |
approved for use
rescue inhaler not for routine use in stable asthma recommended for acute asthma symptoms studied for efficacy in adults studied for efficacy in children studied for long-term use effects studied for safety in pregnancy |
| gptkbp:contraindication |
hypokalemia
hypersensitivity to albuterol paradoxical bronchospasm |
| gptkbp:dosageForm |
as needed
metered-dose inhaler |
| gptkbp:drugInterdiction |
gptkb:MAO_inhibitors
excreted in urine metabolized in the liver prescription required beta-blockers rapid onset of action bronchodilator duration of action 4-6 hours |
| gptkbp:expirationDate |
approximately 12 months
|
| gptkbp:formFactor |
aerosol
|
| gptkbp:formulation |
solution for inhalation
|
| gptkbp:hasPopulation |
children and adults
|
| gptkbp:healthcare |
monitor for side effects
how to use inhaler importance of carrying inhaler monitor for effectiveness recognizing signs of asthma attack |
| https://www.w3.org/2000/01/rdf-schema#label |
Ventolin HFA
|
| gptkbp:incubationPeriod |
shake well before use
exhale fully before inhaling hold breath for 10 seconds after inhalation wait 1 minute between puffs |
| gptkbp:lastProduced |
1981
|
| gptkbp:manufacturer |
gptkb:GlaxoSmithKline
|
| gptkbp:packaging |
pressurized canister
|
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:relatedPatent |
exercise-induced bronchospasm
|
| gptkbp:route |
inhalation
|
| gptkbp:safetyFeatures |
use with caution in patients with heart disease
|
| gptkbp:sideEffect |
headache
nervousness tremors increased heart rate |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
beta-2_adrenergic_agonist
|
| gptkbp:type |
albuterol sulfate
|
| gptkbp:usedFor |
treating chronic obstructive pulmonary disease (COPD)
treating asthma |